PRL3 Promotes Cell Invasion and Proliferation by Down-regulation of Csk Leading to Src Activation*
暂无分享,去创建一个
[1] G. O'Neill,et al. Integrin signalling: a new Cas(t) of characters enters the stage. , 2000, Trends in cell biology.
[2] Michael J. Eck,et al. Three-dimensional structure of the tyrosine kinase c-Src , 1997, Nature.
[3] K. Klinger,et al. Alterations in Vascular Gene Expression in Invasive Breast Carcinoma , 2004, Cancer Research.
[4] R. Jove,et al. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. , 1995, Science.
[5] J. Li,et al. PRL-3 and PRL-1 promote cell migration, invasion, and metastasis. , 2003, Cancer research.
[6] S. Nada,et al. Csk defines the ability of integrin-mediated cell adhesion and migration in human colon cancer cells: implication for a potential role in cancer metastasis , 2004, Oncogene.
[7] J. Blenis,et al. ERK and p38 MAPK-Activated Protein Kinases: a Family of Protein Kinases with Diverse Biological Functions , 2004, Microbiology and Molecular Biology Reviews.
[8] S. Courtneidge. Activation of the pp60c‐src kinase by middle T antigen binding or by dephosphorylation. , 1985, The EMBO journal.
[9] John Kuriyan,et al. Crystal structure of the Src family tyrosine kinase Hck , 1997, Nature.
[10] J. Cooper,et al. Dephosphorylation or antibody binding to the carboxy terminus stimulates pp60c-src , 1986, Molecular and cellular biology.
[11] N. Rahimi,et al. c-Src Kinase Activity Is Required for Hepatocyte Growth Factor-induced Motility and Anchorage-independent Growth of Mammary Carcinoma Cells* , 1998, The Journal of Biological Chemistry.
[12] A. Bardelli,et al. PRL-3 Phosphatase Is Implicated in Ovarian Cancer Growth , 2005, Clinical Cancer Research.
[13] A. Cox,et al. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility. , 2006, Cancer research.
[14] V. Diehl,et al. Profiling of Hodgkin’s Lymphoma Cell Line L1236 and Germinal Center B Cells: Identification of Hodgkin’s Lymphoma-specific Genes , 2003 .
[15] D. Crowell,et al. Prenylation of oncogenic human PTP(CAAX) protein tyrosine phosphatases. , 1996, Cancer letters.
[16] Ken Jacobson,et al. MAP kinases and cell migration , 2004, Journal of Cell Science.
[17] K. Kinzler,et al. PRL-3 expression in metastatic cancers. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[18] J. Darnell. Transcription factors as targets for cancer therapy , 2002, Nature Reviews Cancer.
[19] Timothy J. Yeatman,et al. A renaissance for SRC , 2004, Nature Reviews Cancer.
[20] E. Avizienyte,et al. Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition. , 2005, Current opinion in cell biology.
[21] R. Riggins,et al. Functions of the adapter protein Cas: signal convergence and the determination of cellular responses , 2001, Oncogene.
[22] Joanna M. Sasin,et al. Protein Tyrosine Phosphatases in the Human Genome , 2004, Cell.
[23] Qiang Xu,et al. Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells. , 2004, The American journal of pathology.
[24] S. Ogawa,et al. A novel signaling molecule, p130, forms stable complexes in vivo with v‐Crk and v‐Src in a tyrosine phosphorylation‐dependent manner. , 1994, The EMBO journal.
[25] Xinyang Zheng,et al. Cell transformation and activation of pp60c-src by overexpression of a protein tyrosine phosphatase , 1992, Nature.
[26] D. Critchley. Cytoskeletal proteins talin and vinculin in integrin-mediated adhesion. , 2004, Biochemical Society transactions.
[27] Hua Yu,et al. The STATs of cancer — new molecular targets come of age , 2004, Nature Reviews Cancer.
[28] Michael A. Choti,et al. A Phosphatase Associated with Metastasis of Colorectal Cancer , 2001, Science.
[29] D. V. Von Hoff,et al. PRL phosphatases as potential molecular targets in cancer , 2005, Molecular Cancer Therapeutics.
[30] K. Klinger,et al. Protein tyrosine phosphatase PRL-3 in malignant cells and endothelial cells: expression and function , 2006, Molecular Cancer Therapeutics.
[31] A. Bardelli,et al. PRL-3: A phosphatase for metastasis? , 2004, Cancer biology & therapy.
[32] Y. Shiratori,et al. Reduced C‐terminal Src kinase (Csk) activities in hepatocellular carcinoma , 1999, Hepatology.
[33] R. Jove,et al. Cell transformation by the viral src oncogene. , 1987, Annual review of cell biology.
[34] Y. Tan,et al. Mouse PRL-2 and PRL-3, two potentially prenylated protein tyrosine phosphatases homologous to PRL-1. , 1998, Biochemical and biophysical research communications.
[35] K. Zänker,et al. Differences in the migration capacity of primary human colon carcinoma cells (SW480) and their lymph node metastatic derivatives (SW620). , 1998, Cancer letters.
[36] Y. Shiratori,et al. Reduced C‐terminal Src kinase activity is correlated inversely with pp60c‐src activity in colorectal carcinoma , 2001, Cancer.
[37] M. Kasuga,et al. High Expression of PRL-3 Promotes Cancer Cell Motility and Liver Metastasis in Human Colorectal Cancer , 2004, Clinical Cancer Research.
[38] J. Dixon,et al. Role of PRL-3, a human muscle-specific tyrosine phosphatase, in angiotensin-II signaling. , 2001, Biochemical and biophysical research communications.
[39] Z. Zhang,et al. Protein tyrosine phosphatases: prospects for therapeutics. , 2001, Current opinion in chemical biology.
[40] A. Bardelli,et al. Genetic analysis of the kinome and phosphatome in cancer , 2005, Cellular and Molecular Life Sciences CMLS.
[41] G. Martin. The hunting of the Src , 2001, Nature Reviews Molecular Cell Biology.
[42] Kozo Nakamura,et al. Overexpression of the csk gene suppresses tumor metastasis in vivo , 2000, International journal of cancer.
[43] S. Semba,et al. Expression of PRL-3 Phosphatase in Human Gastric Carcinomas: Close Correlation with Invasion and Metastasis , 2004, Pathobiology.
[44] J. Parsons,et al. Src family kinases, key regulators of signal transduction , 2004, Oncogene.
[45] R. Taub,et al. PRL-1, a unique nuclear protein tyrosine phosphatase, affects cell growth , 1994, Molecular and cellular biology.